10 results
8-K
EX-99.1
LXRX
Lexicon Pharmaceuticals Inc
2 May 23
Lexicon Pharmaceuticals Reports First Quarter 2023
4:03pm
analysis examined the timing of clinical benefit of sotagliflozin, defined as the first day post randomization when the hazard ratio (HR) for risk
8-K
EX-99.1
LXRX
Lexicon Pharmaceuticals Inc
17 Nov 20
Results from Soloist and Scored Outcomes Studies
7:22am
as compared with placebo.
In the SOLOIST study, the primary endpoint was achieved with a hazard ratio (HR) of 0.67 (p<0.001) in people with type 2 … diabetes and a recent hospitalization for worsening heart failure. In the SCORED study, the primary endpoint was achieved with a hazard ratio of 0.74
8-K
EX-10.1
LXRX
Lexicon Pharmaceuticals Inc
22 Oct 20
Entry into a Material Definitive Agreement
7:12am
of the Property may be located on or near an earthquake fault line or in or near an earthquake or seismic hazard zone; (16) the existence of vested land use
8-K
EX-10.1
LXRX
Lexicon Pharmaceuticals Inc
15 Jul 20
Entry into a Material Definitive Agreement
5:06pm
or a portion of the Property may be located on or near an earthquake fault line or in or near an earthquake or seismic hazard zone; (16) the existence
8-K
EX-10.1
LXRX
Lexicon Pharmaceuticals Inc
16 Jan 20
Entry into a Material Definitive Agreement
4:11pm
that all or a portion of the Property may be located on or near an earthquake fault line or in or near an earthquake or seismic hazard zone; (16
8-K
EX-10.1
zv1sdce25s
18 Jun 01
Lexicon Genetics Incorporated - 6/13/01
12:00am
10-K
EX-10.12
zshhgj3rjn
15 Mar 01
Annual report
12:00am
- Prev
- 1
- Next